Efficiency and safety of moxifloxacin in treatment of elderly community acquired pneumonia with renal dysfunction
HANG Chen-chen
WANG Shuo
Abstract：Objective To evaluate the effectiveness and safety of moxifloxacinin treatment of community acquired pneumonia in elderly patients with renal dysfunction , so as to provide safe and effective antibiotics for the treatment of community acquired pneumonia for patients . elderly renal dysfunction .Methods A total of 128 elderly patients with community acquired pneumonia , who enrolled the emergency department of the hospital from Jan 2011 to Dec 2013 , were divided into two groups according to the renal function .The normal group ( n =63 ) and the renal dysfunction group without hemodialysis ( n =65 ) were both treated with moxifloxacin .The clinical efficacies and the adverse reactions were observed .Results There was no statistically difference in the clinical effective rates (81.0% vs.87.7%, P=0.294), the pathogensclearance rate (80.56% vs.88.37%, P=0.335) and the incidence of the adverse reactions (7.93% vs.9.23%, P=0.794) between the two groups.There was no significant difference of moxifloxacin plasma concentration between the two groups at each time point.The plasma concentration was stable in the whole protocol .Conclusion Moxifloxacincan achieve good clinic effect in the treatment of community acquired pneumonia with renal dysfunction in elderly patients with less adverse reaction .
Keywords：MoxifloxacininCommunity acquired pneumoniaElderly patientRenal dysfunction
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 685-688 )